Type 2 Diabetes and Asthma: Systematic Review of the Bidirectional Relationship

Author(s): Louise Rayner*, Andrew McGovern, Ben Creagh-Brown, Chris Woodmansey, Simon de Lusignan.

Journal Name: Current Diabetes Reviews

Volume 15 , Issue 2 , 2019

Submit Manuscript
Submit Proposal

Abstract:

Background and Objective: Obesity is an important contributor to the risk of both asthma and Type 2 Diabetes (T2DM). However, it has been suggested that T2DM and asthma are also independently associated. The aim of this systematic review was to synthesize the evidence for an independent relationship between T2DM and asthma.

Methods: MEDLINE and EMBASE were searched for studies reporting the relationship between asthma and T2DM in adults. Given a potential bidirectional relationship, articles relating to T2DM as a risk factor for asthma, and asthma as a risk factor for T2DM were examined separately.

Results: Eight studies were identified for inclusion in the review (n=2,934,399 participants). Four studies examined incident diabetes in those with asthma. The pooled (random effects model) adjusted hazard ratio for incident T2DM in asthma was 1.37 (95%CI 1.12-1.69; p <0.001) after controlling for BMI.

Four studies reported prevalence or incidence rates of asthma in people with T2DM; higher rates of asthma in those with T2DM were reported in all four studies. Meta-analysis of results was not possible due to methodological heterogeneity.

The quality of included studies was good, but due to small numbers, publication bias cannot be excluded.

Conclusion: The published literature suggests a bidirectional independent relationship between T2DM and asthma, although we cannot exclude publication bias.

Keywords: Type 2 diabetes, asthma, obesity, BMI, incidence, bidirectional relationship.

[1]
Guibas GV, Mathioudakis AG, Tsoumani M, Tsabouri S. Relationship of allergy with asthma: there are more than the allergy “eggs” in the asthma “basket”. Front Pediatr 2017; 5: 92.
[2]
Wenzel SE. Asthma: Defining of the persistent adult phenotypes. Lancet 2006; 368(9537): 804-13.
[3]
Luder E, Ehrlich RI, Lou WYW, Melnick TA, Kattan M. Body mass index and the risk of asthma in adults. Respir Med 2004; 98(1): 29-37.
[4]
Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175(7): 661-6.
[5]
Schatz M, Zeiger RS, Yang SJ, et al. Prospective study on the relationship of obesity to asthma impairment and risk. the journal of allergy and clinical immunology. J Allergy Clin Immunol Pract 2015; 3(4): 560-5 e1.
[6]
Kankaanranta H, Kauppi P, Tuomisto LE, Ilmarinen P. Emerging comorbidities in adult asthma: Risks, clinical associations, and mechanisms. Mediators Inflamm 2016; 2016: 3690628.
[7]
Bell JA, Kivimki M, Hamer M. Metabolically healthy obesity and the risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies. Obes Rev 2014; 15(6): 504-15.
[8]
Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: Findings from the national health and nutrition examination survey epidemiologic follow-up study. Diabetes Care 2004; 27(12): 2966-70.
[9]
Weir DC, Jennings PE, Hendy MS, Barnett AH, Burge PS. Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax 1988; 43(9): 725-6.
[10]
Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010; 33(1): 55-60.
[11]
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med 2009; 151(4): W65-94.
[12]
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-12.
[13]
Booth A, Clarke M, Dooley G, et al. The nuts and bolts of PROSPERO: An international prospective register of systematic reviews. Syst Rev 2012; 1: 2.
[14]
Rayner L, McGovern A, Creagh-Brown B, Woodmansey C, deLusignan S. 2017 Pageshttps.://www.crd.york.ac.uk/prospero/ display_record.asp?ID=CRD42017067421
[15]
Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328(7454): 1490.
[16]
Schwarzer G. R meta-analysis: Package 'meta'. 3.3.2 ed; 2016.
[17]
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-88.
[18]
Green JPHAS. A generic inverse variance approach to metaanalysis. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Collaboration; 2011.
[19]
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16.
[20]
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
[21]
Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004; 27(10): 2478-84.
[22]
Song Y, Klevak A, Manson JE, Buring JE, Liu S. Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women’s Health Study. Diabetes Res Clin Pract 2010; 90(3): 365-71.
[23]
Yun HD, Knoebel E, Fenta Y, et al. Asthma and proinflammatory conditions: A population-based retrospective matched cohort study. Mayo Clin Proc 2012; 87(10): 953-60.
[24]
Mueller NT, Koh WP, Odegaard AO, Gross MD, Yuan JM, Pereira MA. Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study. Diabetes Res Clin Pract 2013; 99(2): 192-9.
[25]
Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials. BMJ 2011; 343: d4002.
[26]
Hashemzadeh M, Movahed MR. The occurrence of asthma in hospitalized patients with type 2 diabetes mellitus. Intern Med J 2009; 39(10): 699-701.
[27]
Thomsen SF, Duffy DL, Kyvik KO, Skytthe A, Backer V. Risk of asthma in adult twins with type 2 diabetes and increased body mass index. Allergy 2011; 66(4): 562-8.
[28]
Chen CZ, Hsu CH, Li CY, Hsiue TR. Insulin use increases the risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort. J Asthma 2017; 54(10): 1019-25.
[29]
Liu S, Tinker L, Song Y, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007; 167(15): 1676-85.
[30]
Shore SA. Obesity and asthma: Possible mechanisms. J Allergy Clin Immunol 2008; 121(5): 1087-93.
[31]
Ahmad T, Kumar M, Mabalirajan U, et al. Hypoxia response in asthma: Differential modulation on inflammation and epithelial injury. Am J Respir Cell Mol Biol 2012; 47(1): 1-10.
[32]
Kim SY, Yoo CG, Lee CT, et al. Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease. J Korean Med Sci 2011; 26(2): 264-7.
[33]
Egbuonu F, Antonio FA, Edavalath M. Effect of inhaled corticosteroids on glycemic status. Open Respir Med J 2014; 8: 101-5.
[34]
Pitocco D, Fuso L, Conte EG, et al. The diabetic lung--a new target organ? RDS 2012; 9(1): 23-35.
[35]
Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987; 135(1): 223-9.
[36]
van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: A metaanalysis. Chest 2010; 138(2): 393-406.
[37]
Brashier B, Salvi S. Obesity and asthma: Physiological perspective. J Allergy 2013; 2013: 198068.
[38]
Savage-Brown A, Mannino DM, Redd SC. Lung disease and asthma severity in adults with asthma: Data from the Third National Health and Nutrition Examination. J Asthma 2005; 42(6): 519-23.
[39]
Bottini P, Scionti L, Santeusanio F, Casucci G, Tantucci C. Impairment of the respiratory system in diabetic autonomic neuropathy. Diabetes Nutr Metab 2000; 13(3): 165-72.
[40]
Li Y, Saito M, Tobimatsu S, et al. Prediabetes and impaired lung function in asymptomatic adults. Diabetes Res Clin Pract 2013; 100(2): e51-4.
[41]
Singh S, Prakash YS, Linneberg A, Agrawal A. Insulin and the lung: connecting asthma and metabolic syndrome. J Allergy 2013; 2013: 627384.
[42]
Singh S, Bodas M, Bhatraju NK, et al. Hyperinsulinemia adversely affects lung structure and function. American journal of physiology. Am J Physiol Lung Cell Mol Physiol 2016; 310(9): L837-45.
[43]
Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108(8): 1167-74.
[44]
Lee JS, Park SJ, Cho YS, Huh JW, Oh YM, Lee SD. Role of AMP-Activated Protein Kinase (AMPK) in smoking-induced lung inflammation and emphysema. Tuberc Respir Dis 2015; 78(1): 8-17.
[45]
Stene LC, and Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 2001; 357(9256): 607-8.
[46]
Maddatu J, Anderson-Bacum E, and Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res 2017; 184: 101-7.
[47]
Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of Type 2 Diabetes Mellitus by changes in lifestyle amongst subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
[48]
Diabetes Australia. Prevention. Available at:. https://www. diabetesaustralia.com.au/prevention [Accessed on: 8/4/18].
[49]
Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: is prevention possible? Lancet 2015; 386(9998): 1075-85.


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 15
ISSUE: 2
Year: 2019
Page: [118 - 126]
Pages: 9
DOI: 10.2174/1573399814666180711114859
Price: $58

Article Metrics

PDF: 21
HTML: 3